IL1B and myeloid sarcoma: Upregulation of IL-1β is observed in a broad spectrum of neurological diseases, including infections, trauma, stroke, and epilepsy, as well as chronic neurologic diseases such as MS, Parkinson’s disease, amyotrophic lateral sclerosis, and Alzheimer’s disease [32]; BBB disruption is associated with progression of these diseases [34].